Skip to content
Log in Get started
Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor
Financial data updated nightly

GlaxoSmithKline Pharmaceuticals Ltd

GLAXO.NS ✓ COMPLIANTFree checks used up today ☆ Track — members
NSE · Healthcare · Pharmaceuticals ·
India Mid Cap Analyst: BUY
Last Close
$26.72
▼ -1.68%
Market Cap $4.53B · Vol 212.24K
Price charts are for members

Interactive price history from intraday to 5 years, on every stock and ETF.

See plans
Key Metrics
P/E Ratio
37.41
FWD: 33.89
Market Cap
$4.53B
Mid Cap
Div Yield
2.21%
Annual dividend
EPS Growth
+12.43%
YoY
RSI (14)
49.25
Momentum
Beta
0.60
vs Market
52W High
$32.94
17.10% below
52W Low
$22.04
24.18% above
Volume
212.24K
Avg 69.12K
P/B
17.06
Price-to-book
ROE
49.11%
Return on equity
Free Float
24.37%
Public shares
Shariah Compliance8 STANDARDS
✓ Yes, GlaxoSmithKline Pharmaceuticals Ltd (GLAXO.NS) stock is Shariah compliant
You’ve used your 10 free compliance checks today

Sign up and choose a plan to keep checking — unlimited checks, all 8 standards, purification and zakat per share.

Choose a plan
  • AAOIFI—
  • Dow Jones Islamic (DJIM)—
  • FTSE Shariah—
  • MSCI Islamic—
  • S&P Shariah—
  • Al Rajhi—
  • Alinma—
  • Albilad—
Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share.Members see the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does GLAXO.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns
5D
+1.35%
1M
-8.64%
3M
-4.35%
6M
+7.74%
YTD
+2.35%
1Y
-4.77%
3Y
+58.84%
5Y
+61.12%
Financials & Valuation
TTM · Annual
Total Revenue$408.92M
Net Income$110.85M
Revenue Growth (YoY)+20.78%
Gross Margin60.10%
Operating Margin32.64%
Net Profit Margin27.11%
ROE49.11%
ROA · ROIC33.35% · 48.71%
P/E Ratio37.41
Forward P/E (FY1)33.89
PEG Ratio3.19
P/S10.12
P/B17.06
P/FCF40.10
EPS Growth+12.43%
Outstanding Shares169.41M
Technical Indicators
50-Day SMA$28.92
200-Day SMA$26.55
RSI (14)49.25
Beta0.60
52-Week High$32.94
52-Week Low$22.04
Volume Today212.24K
Avg Daily Volume (30D)69.12K
Relative Volume3.07x
Volatility (10D)20.33
Volatility (30D)27.32
Free Float24.37%
AAOIFI Certified Shariah Advisor and Auditor certificate